Target RWE
Andrea Rossi Mospan, PhD, RAC, is currently serving as Vice President, Scientific & Medical Affairs, Real World Evidence at Target RWE, and works closely with pharmaceutical partners and key opinion leaders, as well as the cross functional medical affairs, epidemiology, statistical, clinical and data science teams at Target RWE.
Dr. Mospan has over 16 years of experience in the pharmaceutical industry including medical and scientific affairs, clinical development, and regulatory affairs. Previously she was an Associate Director in clinical development at a mid-size pharmaceutical company, Inspire Pharmaceuticals, and led regulatory submissions for integrated product development programs as well as clinical trials as a Senior Research Scientist at a full-service CRO, Rho Inc. Dr. Mospan received a doctorate in Cell and Molecular Physiology from the University of North Carolina at Chapel Hill and has contributed as a co-author to more than 15 manuscripts in addition to over 20 abstracts.
Target RWE
As the industry’s best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives. Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Their rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model.